Abstract
Sputum and endotracheal aspirates (ETs) are not among the vendor-approved specimens for the Cepheid Xpert SARS-CoV-2 assay. However, they are the common lower respiratory tract specimens submitted for laboratory diagnosis. Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lower respiratory tract samples is required for the discharge of patients from coronavirus disease (COVID) units at some institutions. We developed a protocol used for testing unliquified viscous sputum or tracheal aspirate with the Cepheid Xpert SARS-CoV-2 assay.
Author supplied keywords
Cite
CITATION STYLE
Malczynski, M., Rezaeian, S., Rios, J., Dirnberger, L., Polanco, W., Zembower, T., & Qi, C. (2020). Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2. Access Microbiology, 2(12). https://doi.org/10.1099/acmi.0.000176
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.